Milestone Pharmaceuticals Inc (NASDAQ:MIST) currently has a daily average trading volume of 1.04M but it saw 1352641 shares traded in last market. With a market cap of 136.86M USD, the company’s current market price of $2.56 came rising about 6.67 while comparing to the previous closing price of $2.4. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.75 and as low as $0.63. In the recent trading on the day, stock has struck highest price mark of $2.29 while lowest mark touched by it was $2.56.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which resumed the stock as “Buy” in its note to investors issued on June 05, 2025, recommending a price target of $5 for it. Jefferies issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $8 and $4.
Over the week, MIST’s stock price is moving 33.33% up while it is 46.29% when we observe its performance for the past one month. Year-to-date it is 88.24% up and over the past year, the stock is showing an upside performance of 8.47%.
The company is expected to be releasing its next quarterly report on 2025-May-14, for which analysts forecasted an EPS of -0.18 while estimate for next year EPS is -0.82.
Currently, Milestone Pharmaceuticals Inc’s total number of outstanding shares is 53.46M with 4.71% of that held by the insiders while 22.25% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -106.14% and return on equity (ROE) at -307.27%. Stock’s beta reads 0.54. Its return on asset (ROA) is -65.78% on average.
